Joseph Thomas

Joseph Thomas of Scotiabank inquired about Travere's efforts and opportunities to encourage earlier diagnosis and treatment of IgAN, particularly in light of the recent draft KDIGO guideline update.

Answer

Chief Commercial Officer Peter Heerma responded, referencing earlier remarks by CMO Dr. Jula Inrig about FILSPARI's benefits in patients with lower proteinuria. He noted a greater sense of urgency among physicians post-ASN to treat earlier and more aggressively, a trend supported by the new KDIGO guidelines and Travere's data showing consistent efficacy across patient populations.

Joseph Thomas inquired about the outlook for India following the 25% net revenue decline due to tax changes. He also asked for an explanation of structural hold changes across the UK, Australia, and International divisions.

Answer

CEO Peter Jackson reiterated the expectation for the India business to return to positive growth by year-end as the company adapts to the new tax-on-deposits model. CFO Paul Edgecliffe-Johnson explained that structural hold in markets like the UKI is benefiting from more parlays and Bet Builder products, as well as greater promotional efficiency.

Joseph Thomas from HSBC inquired about the outlook for the Indian market following recent tax changes and asked for an explanation of the differing structural hold trends across the UK, Australia, and International divisions.

Answer

CEO Peter Jackson reiterated the expectation that the India business will return to positive growth by year-end as it adapts to the new tax-on-deposits model. CFO Paul Edgecliffe-Johnson explained that structural hold in the UKI is benefiting from more parlays and efficient promotions, and the company is managing these levels carefully.